15 results about "Sparganium stoloniferum" patented technology

This invention provides a traditional Chinese medicine preparation for promoting blood circulation and relieving pain, and its preparation method, relating to the field of traditional Chinese medicine pharmaceutical technology. The preparation is made from the following parts by weight of traditional Chinese medicine raw materials: 10-30 parts of Polygonatum sibiricum, 10-30 parts of Spatholobus suberectus, 10-30 parts of Curcuma longa, 5-20 parts of Sparganium stoloniferum, 5-20 parts of Areca catechu peel, 5-20 parts of Polygonum hydropiper, 5-20 parts of Rhizoma Scutellariae, 1-5 parts of Artemisia argyi, 5-20 parts of Solanum nigrum, 5-20 parts of Catechu, 10-30 parts of Scutellaria barbata, 5-20 parts of Aristolochia debilis, 10-30 parts of Astragalus membranaceus, and 5-20 parts of Artemisia argyi oil. The traditional Chinese medicine preparations described in this invention differ from those that typically enhance the efficacy of a single herb. Instead, they exhibit a synergistic relationship where one plus one equals more than two. The principal, assistant, adjuvant, and guide herbs complement each other, combining both tonifying and purging effects. This approach effectively promotes the dissipation of blood stasis, unblocks the flow of qi and blood in the meridians, eliminates local inflammation, and reduces swelling and pain. Simultaneously, it nourishes the tendons and bones, supports the body's vital energy, and enhances the body's ability to resist pathogens and repair damage. Thus, it comprehensively alleviates pain caused by various factors, achieving the goals of promoting blood circulation, removing blood stasis, clearing the meridians, reducing inflammation and swelling, and relieving pain.

This invention discloses a medicinal mud for treating blood stasis and heat-induced arthralgia, its preparation method, and its application. The medicinal mud is composed of the following raw materials in parts by weight: 30-70 parts of *Hedyotis diffusa*, 30-70 parts of *Caesalpinia sappan*, 30-70 parts of *Gardenia jasminoides*, 30-70 parts of *Rheum palmatum* (processed with wine), 15-45 parts of *Stephania tetrandra*, 10-30 parts of *Sparganium stoloniferum*, 10-30 parts of *Curcuma zedoaria*, 10-30 parts of *Ligusticum chuanxiong*, 10-30 parts of *Smilax glabra*, 10-30 parts of *Geranium wilfordii*, 10-30 parts of *Polygonum cuspidatum*, 5-15 parts of *Cinnamomum cassia*, 5-15 parts of *Cyperus rotundus*, and 5-15 parts of *Citrus reticulata* (green tangerine peel). The above-mentioned treatment method scientifically combines a large number of heat-clearing, blood-cooling, and detoxifying herbs such as gardenia bark, rhubarb, Japanese knotweed, and smilax glabra with powerful blood-breaking and stasis-removing herbs such as sparganium rhizome, turmeric rhizome, sappanwood, and sclerotium tsao-ko. It is also supplemented with herbs that dispel dampness, unblock the meridians, promote qi circulation, and relieve pain. This method directly targets the three core elements of "blood stasis and heat arthralgia": "heat," "stasis," and "congestion." It treats internal diseases from the outside, with significant curative effects, and avoids the systemic toxic side effects of oral medications.

This invention belongs to the technical field of skin disease treatment products, specifically relating to a topical hot compress for treating scleroderma and its preparation method. The topical hot compress for treating scleroderma is made from the following raw materials in parts by weight: 20-40 parts of Artemisia argyi, 20-40 parts of Cinnamomum cassia, 10-20 parts of Sparganium stoloniferum, 10-20 parts of Curcuma zedoaria, 10-20 parts of Loranthus parasiticus, 15-30 parts of Gynostemma pentaphyllum, 10-20 parts of Spirodela polyrhiza, 15-30 parts of Spirodela polyrhiza, 15-30 parts of Ephedra sinica, 20-40 parts of Clematis chinensis, 5-15 parts of Eupolyphaga sinensis, 15-25 parts of Eriocaulon buergerianum, 5-15 parts of Carthamus tinctorius, 3-6 parts of Dracaena cochinchinensis, 3-6 parts of processed Strychnos nux-vomica, 20-40 parts of Vaccaria segetalis, 20-40 parts of Astragalus membranaceus, 10-20 parts of Magnolia officinalis, 10-20 parts of Aconitum carmichaelii, and 22-40 parts of rice wine. This invention is a topical medication that eliminates the need for oral administration, treating the disease externally and guiding the pathogenic factors to a cure. It avoids the inconvenience of bitter medications and effectively relieves symptoms and promotes the cure of localized scleroderma.

The invention provides a preparation method of a compound SS-23 and application of the compound SS-23 in preparation of drugs for preventing and / or treating atherosclerosis, and belongs to the technical field of chemical drugs. The compound SS-23 is a compound as shown in a formula I or a pharmaceutically acceptable salt thereof. The phenolic acid glyceride compound SS-23 is separated and purified from rhizoma sparganii, and the compound can play a role in preventing and / or treating atherosclerosis by adjusting the blood fat level, reducing the plaque area and improving the vascular function. The compound SS-23 has remarkable potential in the aspect of preventing and / or treating atherosclerosis, provides a new treatment strategy for clinic, and has a good application prospect. Formula I.

The invention provides a Chinese herbal compound for treating or improving anxiety disorder and application thereof, and relates to the technical field of Chinese herbal medicines. According to the traditional Chinese medicine compound, cortex albiziae, longan pulp and citron are used as monarch materials, zedoary, buckeye and scirpus yagara are used as ministers, cortex fraxini, fructus chebulae, cortex dictamni, selfheal, lithospermum and liquorice are used as assistants and guides, all the medicines are combined to regulate qi activity, invigorate qi and blood, dissipate stasis and clear away toxin, and the whole formula has the effects of resolving depression, soothing the nerves, soothing the liver, regulating qi, tonifying heart and spleen, activating blood and clearing heat. The traditional Chinese medicine compound can effectively relieve anxiety mood of a patient, refresh sleep quality and improve anxiety expression such as body symptoms of the patient, is remarkable in curative effect, has huge application potential in the aspect of treating or improving anxiety disorder, and is worthy of popularization.

This invention discloses a traditional Chinese medicine composition for reducing swelling and relieving pain, and its preparation method. The composition comprises the following medicinal ingredients: *Lycopodium clavatum*, *Clematis chinensis*, safflower, ephedra, *Pinus tabuliformis*, *Liquidambar formosana*, *Millettia speciosa*, *Tinospora sinensis*, *Caesalpinia sappan*, *Sparganium stoloniferum* (processed with vinegar), *Curcuma zedoaria*, and *Homalomena occulta*. All ingredients in this composition are natural Chinese herbal medicines, making the raw materials readily available, the preparation method simple, the cost low, and the use convenient. It can be mass-produced. This composition can effectively relieve symptoms of swelling and pain, improve the quality of life, and has high social value.

The invention discloses a traditional Chinese medicine composition for treating rhinitis and a preparation method thereof. The traditional Chinese medicine composition comprises traditional Chinese medicine raw materials and functional auxiliary materials, wherein the traditional Chinese medicine raw materials comprise the following medicinal materials in percentage by weight: 12% of biond magnolia flower, 12% of small centipeda herb, 15% of dwarf lilyturf tuber, 3% of wild chrysanthemum flower, 3% of dahurian angelica root, 3% of dandelion, 3% of manchurian wildginger, 3% of cocklebur fruit, 8% of common burreed rhizome, 8% of curcuma zedoary, 10% of red-rooted salvia root, 6% of szechuan lovage rhizome and 6% of thunberg fritillary bulb; the functional auxiliary materials comprise the following raw materials in percentage by weight: 0.4% of cellulase, 0.2% of pectinase, 1.2% of carbomer, 0.8% of poloxamer, 0.1% of glycyrrhetinic acid, 0.05% of limonene, 5.24% of chitosan-sodium alginate and 0.01% of an anti-VEGF antibody. According to the application, a nasal polyp targeting component is added, so that the dual effects of dredging orifices, resisting inflammation (rhinitis) and resisting fiber (nasal polyp) are realized; the clinical value is higher than that of single rhinitis treatment; plant cell walls are destroyed by adopting composite enzymolysis, and fat-soluble, water-soluble and volatile oil active ingredients are synchronously extracted in combination with supercritical CO2 extraction; the mucous membrane stimulation risk caused by impurities is reduced.

The invention discloses a traditional Chinese medicine composition for treating tumor cancer and a preparation method thereof. The traditional Chinese medicine composition is prepared from 20 traditional Chinese medicinal materials including curcuma zedoary, rhizoma sparganii, radix clematidis and the like through a special processing technology. The anti-tumor effect is achieved through triple mechanisms of cell apoptosis induction, angiogenesis inhibition and immunoregulation. The data of the embodiment shows that the IC50 value of the composition to the liver cancer HepG2 cell strain is 8.7 mu g / mL, and the tumor inhibition rate of tumor-bearing mice reaches 63.2%, which is obviously superior to that of a cis-platinum control group. The invention also provides a preferable alcohol extraction-water precipitation combined preparation process.

The application provides a preparation method of a compound SS-23 and an application of the compound SS-23 in preparing medicines for preventing and / or treating atherosclerosis, and belongs to the technical field of chemical medicines. The compound SS-23 is a compound shown in formula I or a pharmaceutically acceptable salt thereof. The phenolic acid glyceride compound SS-23 is obtained by separation and purification from Sparganium stoloniferum Buch. The compound can play a role in preventing and / or treating atherosclerosis by regulating blood lipid levels, reducing plaque area and improving blood vessel function. The compound SS-23 has significant potential in preventing and / or treating atherosclerosis, provides a new treatment strategy for clinic, and has a good application prospect. Formula I.

The invention discloses a mild acidic hair dyeing composition based on indole and plant extracts and a preparation method thereof, and belongs to the technical field of daily chemicals, and the mild acidic hair dyeing composition based on indole and plant extracts is characterized by comprising a dye penetrant and an oxidation color fixing agent which are used separately, the dye penetrant comprises an effective coloring amount of 5, 6-dihydroxyindole or an oligomer thereof, an eclipta prostrata extract and a black sesame extract; the oxidation color fixing agent comprises 0.5-3.0 wt% of hydrogen peroxide, and the hair dye with low damage and high safety is realized through the steps of separating dye penetration and oxidation color fixing.

This invention discloses a traditional Chinese medicine composition for treating liver cirrhosis and its preparation method, belonging to the technical field of anti-cirrhosis traditional Chinese medicine. The raw materials, by weight, are: 10g of Polyporus umbellatus, 10g of Artemisia capillaris, 10g of Bupleurum chinense, 10g of charred rhubarb, 10g of Coptis chinensis, 10g of charred Scutellaria baicalensis, 10g of Gardenia jasminoides, 15g of Lysimachia christinae, 10g of Curcuma longa, 10g of Alisma plantago-aquatica, 10g of Paeonia lactiflora, 10g of Salvia miltiorrhiza, 10g of Magnolia officinalis, 10g of Citrus aurantium, 10g of Cyperus rotundus, 10g of Sparganium stoloniferum, 10g of Curcuma zedoaria, 20g of Plantago asiatica, 10g of Carapax Trionycis, 10g of Areca catechu, 25g of calcined clay, and 2g of charred donkey-hide gelatin. By providing a traditional Chinese medicine composition formula for treating liver cirrhosis, the effectiveness and cure rate of drugs for liver cirrhosis are improved.

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition and application and a preparation method thereof. The traditional Chinese medicine composition is mainly prepared from the following components in parts by weight: 3-35 parts of garden burnet, 2-22 parts of pawpaw, 2-18 parts of radix curcumae, 1-26 parts of radix stephaniae tetrandrae, 2-16 parts of rhizoma atractylodis, 3-13 parts of rhizoma bletillae, 5-23 parts of rhizoma corydalis, 2-20 parts of cortex phellodendri, 1-12 parts of borneol, 25-60 parts of calcined gypsum, 30-70 parts of calamine, 3-18 parts of frankincense, 2-15 parts of myrrh and 2-17 parts of dragon's blood. The traditional Chinese medicine is prepared from the following components in parts by weight: 2-16 parts of hematoxylon, 3-13 parts of rhizoma sparganii, 3-15 parts of notopterygium root, 2-16 parts of pseudo-ginseng and 85-150 parts of sesame oil. The traditional Chinese medicine composition disclosed by the invention is suitable for various long-term non-healing wounds with unknown reasons, such as long-term non-healing wounds caused by postoperative, infection, burn and diabetic foot, and sore and ulcer diseases such as chilblain, ecthyma, bedsore and the like, and has a remarkable curative effect.

The application discloses a traditional Chinese medicine composition for treating triple-negative breast cancer and a preparation method and application thereof. The traditional Chinese medicine composition is composed of Ranunculus japonicus, Alocasia cucullata, centipede, Prunella vulgaris, Curcuma zedoaria, Sparganium stoloniferum, Schisandra chinensis, Euphorbia neriifolia, Solanum nigrum, green calyx, Albizia julibrissin, pericarpium citri reticulatae, Radix Clematidis, Radix Paeoniae Alba, fried Atractylodes, and Rhizoma Belamcandae. The application is aimed at the pathogenesis of triple-negative breast cancer, i.e. liver depression, qi stagnation, phlegm and blood stasis, and deficiency of healthy qi. The whole prescription has the functions of soothing liver and relieving depression, resolving phlegm and removing stasis, promoting blood circulation and removing blood stasis, and supporting healthy qi and resisting cancer. Pharmacodynamic experiments show that the traditional Chinese medicine composition can increase the expression level of DNA damage marker gamma-H2AX, and promote cell apoptosis by inducing DNA damage of tumor cells.

This invention discloses a cultivation regulation method, soil evaluation method, and their application based on the characteristics of rhizosphere soil microorganisms of different sexes of *Calamus fragilis*, belonging to the field of medicinal plant cultivation and agricultural microecology technology. This method determines the soil microecological state by detecting the bacterial α-diversity index, relative abundance of dominant and specific bacterial groups in the rhizosphere soil of *Calamus fragilis*, and combining this with physicochemical indicators such as total carbon, total nitrogen, and total phosphorus. When the soil is determined to be in a male-type microecological state unfavorable to the formation of female plants, donor soil, microbial enrichment, or special microbial agents derived from the rhizosphere soil of female plants or mixed female-male plant rhizosphere soil are applied to reconstruct a rhizosphere microecological environment conducive to the formation and growth of female plants. This invention can be used to increase the female plant rate of *Calamus fragilis*, improve the yield of medicinal seeds, optimize crop rotation / intercropping systems, and restore the microecology of planting soil, showing promising application prospects.